|
ZNF496 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.11900000049548E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.12219999998309E-06 |
| Normal-vs-Stage2 |
4.360100E-04 |
| Normal-vs-Stage3 |
3.72010000027068E-07 |
| Normal-vs-Stage4 |
4.361700E-04 |
| Stage1-vs-Stage2 |
9.804800E-01 |
| Stage1-vs-Stage3 |
3.126800E-01 |
| Stage1-vs-Stage4 |
9.968400E-01 |
| Stage2-vs-Stage3 |
4.949400E-01 |
| Stage2-vs-Stage4 |
9.819800E-01 |
| Stage3-vs-Stage4 |
4.725000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.25299999997885E-06 |
| Normal-vs-AfricanAmerican |
2.898400E-02 |
| Normal-vs-Asian |
6.355600E-04 |
| Caucasian-vs-AfricanAmerican |
2.978000E-01 |
| Caucasian-vs-Asian |
7.305600E-01 |
| AfricanAmerican-vs-Asian |
4.538200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50777999999852E-05 |
| Normal-vs-Female |
5.67830000020031E-07 |
| Male-vs-Female |
7.696000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.83969999999678E-05 |
| Normal-vs-Age(41-60Yrs) |
2.68480000009674E-07 |
| Normal-vs-Age(61-80Yrs) |
3.88700000000242E-05 |
| Normal-vs-Age(81-100Yrs) |
2.023900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.191800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.083400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.897600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.382800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.263200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.502400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.239100E-03 |
| Classical-VS-Follicular |
1.091970E-02 |
| Classical-VS-Other |
1.983370E-01 |
| Classical-VS-Normal |
6.28419999999519E-05 |
| Tall-VS-Follicular |
7.642400E-01 |
| Tall-VS-Other |
7.175000E-01 |
| Tall-VS-Normal |
4.42689999990975E-07 |
| Follicular-VS-Other |
7.014000E-01 |
| Follicular-VS-Normal |
7.56810000002162E-07 |
| Other-VS-Normal |
6.115700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.04329999978314E-07 |
| Normal-vs-N1 |
5.92529999999813E-05 |
| N0-vs-N1 |
9.343400E-01 |
|
|
